Obesity Treatment: Drugs, Surgical Options and Popular Diets Flashcards
Currently Available Options
Options:
1. Accept weight where it is
- Diet/Exercise: 3-10% weight loss
- Drugs: 5-12% weight loss
- Medically Supervised/Combination
of Diet + Drug: 10-15% weight loss - Surgery: 15-30% weight loss
Greater weight loss= greater risk and cost
There are essentially 4 options for overweight and obese people in dealing with their weight.
a. The first is to accept their weight where it is, and the likelihood that they will experience gradual progressive weight gain.
b. The second option is to try to modify their diet and/or physical activity behaviors.
c. The third option is weight loss medications and the fourth option is weight loss surgery.
d. These options go from minimal effectiveness and minimal cost/risk to maximal effectiveness and substantially greater costs/risk.
i. There is no one right approach for all patients, but in general all patients should start with diet and exercise approaches before progressing on to more aggressive treatment approaches.
e. Most people who come to see their doctor asking about weight loss medications or surgery however, have already tried diet and exercise and have reached the conclusion in that these approaches will not work for them.
When to give medications? What about surgery for obesity?
- Medications can start when BMI goes over 30
2. Surgery when BMI goes over 40… or if the BMI is 35 with a Co-morbidity
Medications that may promote weight gain:
a. Anti-diabetic medications
i. Sulfonylureas
ii. Insulin
iii. TZDs
b. Mood Stabilizers, antipsychotics
c. Birth Control Pills: Depo Provera
d. Glucocorticoids: Prednisone
PharmacologicalTreatment of Obesity
a. Current medications 5-12% wt loss
b. Benefits only last as long as patient takes the medication. Chronic treatment likely needed.
c. Drugs probably not paid for by insurance so cost is a big issue for patients.
d. Issues of FDA approval, long term safety, and efficacy.
e. Choice of mechanisms, OTC versus prescription, combinations?
Phentermine:
Large Summary
a. It is chemically related to amphetamine and increases brain norepinephrine levels. It does not have the abuse potential of amphetamine.
b. It is available as a generic and so is inexpensive ($20-40/month).
c. It is currently the most widely prescribed weight loss drug on the market, largely because of the low cost. The doses used ranges from 7-37.5 mg/day.
d. The average weight loss provided is roughly 5% of baseline weight although there is a range of responses with some people losing more and some losing no weight at all.
e. The drug acts centrally to increase satiety and thereby reduce food intake.
i. What the person experiences is fullness at the end of the meal that allows them to reduce portion sizes.
f. The primary side effects are nervousness, difficulty sleeping, headache and dry mouth.
i. The concerning side effect is an increase in blood pressure that occurs in roughly 1-2% of people taking the drug. For this reason it should not be prescribed to patients with uncontrolled hypertension.
ii. If a person has a normal blood pressure the drug should be prescribed at a low dose and the blood pressure checked 7-10 days after starting the drug to make sure it has not risen.
Phentermine: Important Points
*know for test
a. Increases NE content in the brain
b. Chemically related to amphetamine, ‘not addictive’
c. Dose: 15-37.5 mg/d,
d. Cost: $15-25.00/month Cheapest
e. FDA approved for only 3 months use
f. 5-8% weight loss
g. Side effects: hypertension, headache, nervousness
Phentermine Viewpoint
a. Most widely prescribed anti-obesity drug
b. No evidence of serious long term side effects when used as a single drug
c. Is it ethical to prescribe long term? Legally? Beneficience Non-Maleficience Autonomy
Orlistat (Xenical)
a. Pancreatic Lipase inhibitor
b. Inhibits fat absorption by 30%
c. 120 mg three times per day
d. Cost: $100.00/mo
e. GI side effects: oily stools, urgency
i. MVI (multivitamin) to prevent fat soluble vitamin deficiency
Orlistat Study
a. Thousands of patients studied up to 4 years of exposure.
b. Safest weight loss medication, approved for long term use, OTC form
c. 5-8% weight loss on average
d. May be useful in those with poorly controlled hypertension or psych problems
Orlistat (over the counter version: Alli, prescription version: Xenical)
Large Summary
a. Orlistat is a pancreatic lipase inhibitor that blocks dietary fat absorption from the GI tract.
b. The prescription dose is 120 mg taken with each meal.
i. The OTC dose is 60 mg.
c. The cost is between $90-200/ month.
d. The weight loss is similar to phentermine, about 5% of baseline weight with some patients losing more some losing less.
i. Critical*–> Safest weight loss medication, approved for long term use, OTC form
e. Since it is not systemically absorbed, there are no systemic side effects.
i. The primary side effects relate to its mechanism of action.
ii. Patients may notice oily stools, a sense of urgency, some diarrhea or oily leakage.
iii. A theoretical side effect is deficiency of fat soluble vitamins. This is not common, but it is recommended that people on this medication take a daily multivitamin.
Lorcasarin (Belviq)
Major points
*Know this for test
a. Serotonin 2C receptor agonist
b. Previous serotonin agonists fenfluramine and dexfenfluramine caused cardiac valve disease, removed from market
c. 2C receptor only in the brain not in heart
d. Studies in 1-2,000 people for up to 2 years do not show evidence if valvulopathy with lorcasarin.
e. Weight loss: 4-5% no better than phentermine or orlistat
f. Least side effects: minimal headache, dizziness and nausea
g. Cost: $220/mo
i. Unclear if physicians will prescribe off label with phentermine (no data on safety or efficacy)
Lorcasarin (Belviq)
Pros and Cons
a. Weight loss: 4-5% no better than phentermine or orlistat
b. Least side effects: minimal headache, dizziness and nausea
c. Cost: $220/mo
d. Unclear if physicians will prescribe off label with phentermine (no data on safety or efficacy)
Lorcasarin (Belviq): Large summary
know for test
Was recently approved by the FDA.
a. It is a selective serotonin 2C receptor agonist.
i. This is the latest weight loss drug that acts through serotonin.
b. The thought is that the 2C receptors are only found in the brain and not on the heart and so this newer drug will have the weight loss benefits without the cardiac toxicity.
c. Studies demonstrate that lorcasarin at a dose of 10 mg/d produces 4-5 % weight loss
i. no evidence of cardiac valve problems in patients followed out to 2 years of exposure to the drug.
d. Lorcasarin costs about $100/mo (220 according to slides) and is currently approved for long term use.
e. *The obvious question is whether lorcasarin when combined with phentermine will have a similar level of efficacy. No data currently exist to answer this question.
What is the safest weight loss medication?
Orlistat
a. Pancreatic Lipase inhibitor
i. Inhibits fat absorption by 30%
ii. 120 mg three times per day
iii. Cost: $100.00/mo
iv. GI side effects: oily stools, urgency
- MVI to prevent fat soluble vitamin deficiency
b. Thousands of patients studied up to 4 years of exposure.
c. Safest weight loss medication, approved for long term use, OTC form
d. 5-8% weight loss on average
e. May be useful in those with poorly controlled hypertension or psych problems